Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia
Learn more about:
Related Clinical Trial
A Study of Ruxolitinib and Duvelisib in People With Lymphoma
Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia
ABC008 in Subjects With T-cell Large Granular Lymphocytic Leukemia (T-LGLL)
Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)
Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors
Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia
Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte Leukemia
Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia
Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia
Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte Leukemia